Guanosine triphosphate
Based on 6 publication(s) in Google Scholar
Guanosine triphosphate (GTP) is a critical nucleotide and regulator of cellular metabolism. Guanosine triphosphate promotes ribosomal DNA localization, pre-rRNA transcription and ribosome biogenesis by binding to RNA polymerase I and GPN proteins (GPN1/3). Guanosine triphosphate links MYC-dependent ribosome biogenesis to nucleotide sufficiency, acts as a metabolic gatekeeper supporting protein synthesis, DNA/RNA synthesis and cellular signal transduction, while also participating in the physiological activities of pancreatic β-cells and serving as an oxidative substrate for reactive oxygen species. In small cell lung cancer with high MYC expression, Guanosine triphosphate accumulates through the IMPDH-driven synthetic pathway, thereby affecting apoptosis and mitotic processes. Guanosine triphosphate is used in the research of small cell lung cancer, hepatoblastoma and cellular metabolism.
For research use only. We do not sell to patients.
- CAS No.: 86-01-1
- Formula: C10H16N5O14P3
- Molecular Weight:523.18
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Guanosine triphosphate
MoreAll Endogenous Metabolite Isoforms
MoreAll DNA/RNA Synthesis Isoforms
More
Biological Activity
|
RNA Polymerase |
Human Endogenous Metabolite |
Primary MYC-high human small-cell lung cancer tumors have elevated endogenous guanosine triphosphate levels independent of proliferation status[1].
Guanosine triphosphate (GTP depletion via 1 μM MPA; 12 h) reduced protein synthesis in chemoresistant DMS53-CR human small-cell lung cancer cells, while restoring guanosine triphosphate levels (20 μM guanosine; 12 h) rescued protein synthesis activity[1].
Guanosine triphosphate binding to MYC-upregulated GPN1 and GPN3 GTPases is required for RNA polymerase I localization, ribosome biogenesis, and proliferation in MYC-high H82 human small-cell lung cancer cells, and constitutively GTP-bound GPN1/GPN3 mutants protect cells from guanosine triphosphate depletion-mediated inhibition of these activities[1].
Depletion of cellular GTP (1 μg/ml mycophenolic acid; 1-24 h) in HIT-T15 insulin-secreting β-cells potently inhibits mitogenesis, with significant inhibition observed as early as 1 hour and near-complete inhibition after 6-24 hours of treatment[2].
Depletion of cellular GTP (1.6-6.3 μg/ml mycophenolic acid; 18 h) in HIT-T15 and INS-1 insulin-secreting β-cells inhibits Ca2+-stimulated insulin secretion[2].
Guanosine triphosphate (1 mM; 4 h at 37 °C) undergoes oxidation to oxo8GTP in the presence of a ROS-generating system (1 mM L-ascorbic acid + 10 μM cupric sulfate), with oxo8GTP levels increasing ~4-fold and GTP levels showing a small significant decrease relative to control[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HIT-T15 insulin-secreting β-cells, INS-1 insulin-secreting β-cells
-
Concentration:0.3-10 μg/ml mycophenolic acid (HIT-T15 cells, GTP depleted to apoptosis-inducing levels); 25 μg/ml mycophenolic acid (INS-1 cells, GTP depleted to apoptosis-inducing levels)
-
Incubation Time:24-96 h (HIT-T15 cells); 48 h (INS-1 cells)
-
Result:Reduced HIT-T15 cell number by 70% after 48 hours of 3 μg/ml mycophenolic acid treatment, with parallel reductions in DNA, protein, and insulin content.
Reduced MTS formazan production by 30% (0.3 μg/ml, 48 h) to 80% (1 μg/ml, 96 h) in HIT-T15 cells. Induced apoptotic nuclear changes in 29% (1 μg/ml), 49% (3 μg/ml), and 70% (10 μg/ml) of HIT-T15 cells after 48 hours of treatment.
Increased oligonucleosome enrichment factor to ~3.5-fold of control in HIT-T15 cells after 48 hours of treatment.
Revealed chromatin condensation/margination in 25% and apoptotic bodies in 16% of HIT-T15 cells via electron microscopy after 48 hours of treatment.
Increased oligonucleosome enrichment factor to ~3-fold of control and induced apoptotic nuclear changes in INS-1 cells after 48 hours of 25 μg/ml mycophenolic acid treatment.
Chemical Information
-
CAS No. 86-01-1
-
Molecular Weight 523.18
-
Formula C10H16N5O14P3
-
SMILES
O[C@H]1[C@@H](O)[C@H](N2C(N=C(N)NC3=O)=C3N=C2)O[C@@H]1COP(OP(OP(O)(O)=O)(O)=O)(O)=O
-
Synonyms
GTP
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Cancer Commun (Lond)
Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma. [Abstract]2025 May 29. PMID: 40443016 -
Acta Pharm Sin B
Super-resolution imaging for in situ monitoring sub-cellular micro-dynamics of small molecule drug. [Abstract]2024 Apr;14(4):1864-1877. PMID: 38572114 -
J Mol Biol
2024 Apr 15;436(8):168513. PMID: 38447889 -
Bioorg Med Chem
Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants. [Abstract]2021 Jan 1:29:115899. PMID: 33285409 -
STAR Protoc
Protocol to identify the signaling network of nucleotide second messengers in Shigella sonnei. [Abstract]2026 Mar 20;7(1):104353. PMID: 41671092 -
Purity & Documentation
References
[1]. Huang F, et al. Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer. J Clin Invest. 2021;131(1):e139929. [Content Brief]
[2]. Li G, et al. Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis. Endocrinology. 1998;139(9):3752-3762. [Content Brief]
[3]. Bolin C, et al. Assessing biomarkers of oxidative stress: analysis of guanosine and oxidized guanosine nucleotide triphosphates by high performance liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;856(1-2):121-130. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)